Eyeloom
Eyeloom is developing a smartphone-based AI eye screening system for the early detection of serious eye diseases. Leveraging advanced AI models trained on millions of retinal images, Eyeloom aims to identify subtle indicators of conditions like diabetic retinopathy, glaucoma, and macular degeneration, which can be missed in routine exams. The technology achieves over 95% accuracy in clinical validation and can detect 8+ eye diseases. Eyeloom's business model appears to be centered around providing accessible, convenient screening, as simple as taking a selfie, with results and recommendations delivered instantly. The company is currently in the FDA approval process and is targeting a limited beta release in Q3 2025.
Eyeloom
Eyeloom is developing a smartphone-based AI eye screening system for the early detection of serious eye diseases. Leveraging advanced AI models trained on millions of retinal images, Eyeloom aims to identify subtle indicators of conditions like diabetic retinopathy, glaucoma, and macular degeneration, which can be missed in routine exams. The technology achieves over 95% accuracy in clinical validation and can detect 8+ eye diseases. Eyeloom's business model appears to be centered around providing accessible, convenient screening, as simple as taking a selfie, with results and recommendations delivered instantly. The company is currently in the FDA approval process and is targeting a limited beta release in Q3 2025.